This report has been updated. Click here to view latest edition.
If you have previously purchased the archived report below then please use the download links on the right to download the files.
电子皮肤贴片 2021-2031
最全面地评估柔性可穿戴智慧皮肤贴片的商业化
显示全部
说明
内容、图表列表
常见问题解答
价格
Related Content
This report characterizes the markets, technologies and players in electronic skin patches. With coverage across 28 application areas and 127 companies, historic market data from 2010-2020 and market forecasts from 2021 to 2031, it is the most comprehensive study compiled for this product area. It reveals significant opportunity, with the sector passing $10bn in annual revenue from electronic skin patches in 2021, and a forecast for this to grow to over $30bn by 2031.
Skin patches are wearable products attached to the skin. The electronic element involves the integration of electronic functionality such as sensors, actuators, processors and communication, allowing products to become connected and "smart". In many ways, skin patches act as the ultimate wearable electronic devices, augmenting the wearer with minimal encumbrance and maximum comfort. As such, interest in electronic skin patches soared as a by-product of the significant hype and market growth around "wearables" starting in 2014.
However, several product types within the sector transcend this hype. Several skin patch product areas, particularly in diabetes management, cardiovascular monitoring, and other vital sign monitoring, have superseded incumbent options in established markets to create billions of dollars of new revenue each year for the companies at the forefront of this wave. However, success is not ubiquitous; each market discussed within this report sits within a unique ecosystem, with different players, drivers, limitations and history to build on.
As such, the report looks at each of the application areas for electronic skin patches in turn, discussing the relevant technology, product types, competitive landscape, industry players, pricing, historic revenue, and market forecasts. The areas covered include diabetes management, cardiovascular monitoring devices (MCT, Holter monitors, Event monitors, and related products), medical patient monitoring (both inpatient and outpatient), motion sensing, temperature sensing, drug and cosmetic delivery patches, electrical stimulation devices, emerging options towards smart wound care and more. The report contains historic revenue data for each of the product sectors studied back to 2010, including data by company for the larger sectors. The report also contains detailed market forecasting over 10 years for each of the key application areas.
28 application areas discussed within the report
Source IDTechEx
The product category of "electronic skin patches" conceals a significant amount of diversity. Whilst many people may imagine skin patches to be thin, highly conformable devices that sit close to the skin, the reality is that many of the most successful products today are still relatively bulky devices. As such, each chapter within the report also contains a discussion of technology areas relevant to the future development of smart patches, particularly around areas such as flexible, stretchable and conformal electronic components. Development of these technologies will not only enable more products to be deployed as skin patches but will also improve the form factor of electronic skin patches that already exist. This is also covered extensively in IDTechEx's other work in topics such as flexible electronic, stretchable electronics, thin and flexible batteries, smart textiles and other related topics.
The research behind the report has been compiled over several years by IDTechEx analysts. It follows existing coverage of areas such as wearable technology, flexible electronics, stretchable and conformal electronics, electronic textiles, advanced wound care, bioelectronics, sensors and other medical devices. The methodology involved a mixture of primary and secondary research, with a key focus on speaking to executives and scientists from companies developing commercial electronic skin patches. As such, the report compiles case studies of 127 companies and projects, each updated over time and compared within their appropriate product ecosystems.
Source IDTechEx
Unique position and experience behind the report
IDTechEx is afforded a particularly unique position in covering this topic. The experienced analyst team builds on decades of experience covering emerging technology markets, and particularly areas, such as flexible electronics, which are central to electronic skin patches. This has been historically supported by IDTechEx's parallel activities in organising the leading industry conferences and exhibitions covering flexible and wearable electronics, as well as smaller events covering specific innovation trends such as for healthcare sensors or related areas. IDTechEx has the unique ability to curate a network in these topic areas, facilitating the reporting in this report.
从 IDTechEx 访问分析师
所有报告购买订单均包括与一名专家分析师进行 30 分钟的电话交谈，专家分析师将帮助您将报告中的重要发现与您正在处理的业务问题联系起来。这需要在购买报告后的三个月内使用。
更多信息
如果您对这一报告有任何疑问，请随时联系我们的报告团队 research@IDTechEx.com 或致电我们的销售经理：
ASIA (Korea): +82 10 3896 6219
ASIA: +81 70 3152 1209
| 1. | EXECUTIVE SUMMARY |
| 1.1. | Executive introduction: Electronic skin patches |
| 1.2. | Application overview |
| 1.3. | Applications, market sizes and outlook |
| 1.4. | The diabetes management ecosystem |
| 1.5. | CGM leads the way |
| 1.6. | Insulin pumps and patch pumps |
| 1.7. | The outlook for diabetes management |
| 1.8. | Monitoring the heart via skin patches |
| 1.9. | Players and product types in cardiac monitoring |
| 1.10. | Cardiac monitoring skin patches: Historic data: 2010-2020 |
| 1.11. | Cardiac monitoring skin patches: Market forecasts |
| 1.12. | Application potential for general purpose devices |
| 1.13. | Historic market data, 2010-2020 |
| 1.14. | Market forecasts, 2021-2031 |
| 1.15. | Skin patch temperature sensing: Use cases across 13 case studies |
| 1.16. | Key conclusions: Temperature sensing skin patches |
| 1.17. | Electrical stimulation product types |
| 1.18. | Skin patches in bioelectronic medicine |
| 1.19. | Electrical stimulation via skin patches: Market data (2010-2019) |
| 1.20. | Electrical stimulation via skin patches: Market forecast (2021-2031) |
| 1.21. | Iontophoresis via skin patches: Market data (2010-2019) |
| 1.22. | Iontophoresis via skin patches: Market forecast (2020-2030) |
| 1.23. | Key conclusions: Iontophoresis |
| 1.24. | Examples of players from case studies |
| 2. | INTRODUCTION |
| 2.1.1. | The case for skin patches: Augmenting the human body |
| 2.1.2. | The case for skin patches: Improving device form factor |
| 2.1.3. | Definitions and exclusions |
| 2.1.4. | History of skin patches |
| 2.1.5. | Applications, market sizes and outlook |
| 2.1.6. | Reimbursement drives commercial business models |
| 2.1.7. | Patents: Total active patents by assignee |
| 2.1.8. | Patents over time |
| 2.1.9. | Patents: Active and strong patents by assignee |
| 2.1.10. | Context: Wearables hype |
| 2.1.11. | Glossary |
| 2.1.12. | Glossary (continued) |
| 2.2. | Application overview |
| 2.2.1. | Skin patches competing with established products |
| 2.2.2. | New market creation around skin patches |
| 2.2.3. | Section contents |
| 3. | DIABETES MANAGEMENT VIA SKIN PATCHES |
| 3.1.1. | Background: Introduction to diabetes |
| 3.1.2. | The prevalence of diabetes |
| 3.1.3. | Background: Diabetes on the rise |
| 3.1.4. | Background: The cost of diabetes |
| 3.1.5. | Background: The diabetes management process |
| 3.1.6. | Diabetes management ecosystem |
| 3.1.7. | Diabetes management device roadmap: Summary |
| 3.1.8. | Diabetes management device roadmap: Sensors |
| 3.1.9. | Coverage in this report |
| 3.2. | Continuous glucose monitoring (CGM) |
| 3.2.1. | The case for continuous glucose monitoring (CGM) |
| 3.2.2. | Anatomy of a typical CGM device |
| 3.2.3. | CGM is deployed via skin patches |
| 3.2.4. | Comparison metrics for CGM devices |
| 3.2.5. | Example: Accuracy of CGM devices over time |
| 3.2.6. | CGM: Technology |
| 3.2.7. | CGM sensor chemistry |
| 3.2.8. | Sensor filament structure |
| 3.3. | CGM: Overview of key players |
| 3.3.1. | CGM: Overview of key players |
| 3.3.2. | Abbott Laboratories: Introduction |
| 3.3.3. | Abbott Laboratories: CGM business |
| 3.3.4. | Abbott: Freestyle® Libre |
| 3.3.5. | Abbott: "Wired enzyme" |
| 3.3.6. | Abbott: Device and sensor structure |
| 3.3.7. | Dexcom: Introduction |
| 3.3.8. | Dexcom: CGM products |
| 3.3.9. | Dexcom: Sensor structure |
| 3.3.10. | Medtronic: Introduction |
| 3.3.11. | Medtronic: Diabetes & CGM business |
| 3.3.12. | Medtronic: Sensor structure |
| 3.3.13. | Medtronic: Towards closed loop |
| 3.3.14. | Medtronic: Patents in CGM |
| 3.3.15. | Roche: Overview |
| 3.3.16. | Roche: Patents in CGM |
| 3.3.17. | Senseonics |
| 3.3.18. | Ascensia & POCTech |
| 3.3.19. | Medtrum |
| 3.3.20. | Medtrum: CGM devices & insulin pumps |
| 3.3.21. | Medtrum: Sensing technology |
| 3.3.22. | Medtrum: Specific development steps towards the artificial pancreas |
| 3.3.23. | Medtrum |
| 3.3.24. | AgaMatrix & WaveForm Technologies |
| 3.3.25. | Infinovo |
| 3.3.26. | PKVitality |
| 3.3.27. | Sano |
| 3.3.28. | Verily / Google: Contact lenses |
| 3.4. | Non-invasive glucose monitoring |
| 3.4.1. | Background: Glucose in the body |
| 3.4.2. | Assessment of different analytes for glucose monitoring |
| 3.4.3. | Key criteria for assessing accuracy |
| 3.4.4. | In Context: FDA requirements |
| 3.4.5. | Approaches for non-invasive glucose monitoring |
| 3.4.6. | Companies Using Each Technique |
| 3.4.7. | Companies Using Each Technique (Other Fluids) |
| 3.4.8. | When will non-invasive glucose monitoring be commercialised? |
| 3.4.9. | Notable Quotes on Non-Invasive Glucose Monitoring |
| 3.5. | Insulin delivery |
| 3.5.1. | Insulin delivery: Introduction |
| 3.5.2. | Diabetes management device roadmap: Insulin delivery |
| 3.5.3. | Insulin pumps: Introduction |
| 3.5.4. | Insulin pumps currently available |
| 3.5.5. | Insulin pump breakdown |
| 3.5.6. | Insulin patch pumps |
| 3.5.7. | Example: Patch pumps at Medtronic? |
| 3.5.8. | Pricing models for patch pumps vs traditional options |
| 3.5.9. | Insulin pump market |
| 3.5.10. | Insulin pump players and market share |
| 3.5.11. | Markets: Patch pumps vs traditional infusion pumps |
| 3.5.12. | Comparing insulin pumps and CGM |
| 3.5.13. | Outlook for insulin pumps |
| 3.6. | Linking insulin pumps and CGM: Towards closed loop and the artificial pancreas |
| 3.6.1. | Today: Hybrid closed loop systems |
| 3.6.2. | Example: Progress from Medtronic |
| 3.6.3. | The objective: Closing the feedback loop |
| 3.6.4. | Examples and partnerships |
| 3.6.5. | Example: DiabeLoop |
| 3.6.6. | Medtrum: Efforts towards the artificial pancreas |
| 3.7. | Market data: Historic & forecasts |
| 3.7.1. | Skin patches and diabetes: Forecast summary |
| 3.7.2. | Overview: CGM market share and players in 2020 |
| 3.7.3. | A shifting focus in diabetes management, Historic data: 2010-2020 |
| 3.7.4. | Test strip business in decline |
| 3.7.5. | The growth of CGM accelerates |
| 3.7.6. | The insulin pump market |
| 3.7.7. | Markets: Patch pumps vs traditional infusion pumps |
| 3.7.8. | Quantitative forecasts for diabetes and CGM |
| 3.7.9. | Building a top-down forecast scenario |
| 3.7.10. | CGM: Market forecast (revenue) |
| 3.7.11. | CGM: Market forecast (sales volumes) |
| 3.7.12. | Insulin pumps: Market forecast (revenue) |
| 3.7.13. | Insulin pumps: Market forecast (sales volumes) |
| 3.7.14. | Full datasets: Skin patches in diabetes management, 2010-2020 (historic) & 2021-2031 (forecast) |
| 3.7.15. | Full datasets: Diabetes management markets, 2010-2020 (historic) & 2021-2031 (forecast) |
| 4. | GENERAL PATIENT MONITORING: VITAL SIGNS AND RELATED METRICS |
| 4.1. | Introduction |
| 4.1.1. | Introduction |
| 4.1.2. | Drivers and requirements for skin patches |
| 4.1.3. | Application potential for general purpose devices |
| 4.1.4. | Deployment challenges for general monitoring devices |
| 4.1.5. | Evolving market dynamics over time |
| 4.1.6. | General monitoring needs an infrastructure that only the larger players can provide |
| 4.1.7. | Historic market data, 2010-2020 |
| 4.1.8. | Market forecasts, 2021-2031 |
| 4.2. | Inpatient monitoring |
| 4.2.1. | Traditional inpatient monitoring |
| 4.2.2. | The case for removing the wires |
| 4.2.3. | Emerging skin patch options |
| 4.2.4. | Players and approaches |
| 4.2.5. | Philips |
| 4.2.6. | BioIntelliSense |
| 4.2.7. | VivaLNK |
| 4.2.8. | The Surgical Company (formerly Sensium) |
| 4.2.9. | VitalConnect |
| 4.2.10. | Isansys Lifecare |
| 4.2.11. | Market data and forecasts for wireless inpatient monitoring |
| 4.3. | Outpatient monitoring with skin patches |
| 4.3.1. | Introduction |
| 4.3.2. | LifeSignals |
| 4.3.3. | Samsung |
| 4.3.4. | MC10 |
| 4.3.5. | DevInnova / Scaleo Medical |
| 4.3.6. | Avanix |
| 4.3.7. | Avanix - business model and target milestones |
| 4.3.8. | Historic: Qualcomm Life |
| 4.3.9. | Qualcomm Life / Capsule Technologies |
| 4.3.10. | Market data and forecasts for wireless outpatient monitoring |
| 5. | CARDIOVASCULAR MONITORING SKIN PATCHES |
| 5.1.1. | Introduction - Cardiovascular monitoring via wearable devices |
| 5.1.2. | Introduction - Measuring biopotential |
| 5.1.3. | Technology overview - the circuitry for measuring biopotential |
| 5.1.4. | Introduction - Electrocardiography (ECG, or EKG) |
| 5.1.5. | Devices for cardiac monitoring |
| 5.1.6. | Cardiac monitoring device types - skin patches |
| 5.1.7. | Companies and product types |
| 5.1.8. | Technology overview - electrode properties |
| 5.1.9. | Disposable Ag/AgCl electrodes |
| 5.1.10. | Electrodes: Traditional approaches |
| 5.1.11. | Skin patches with disposable electrodes |
| 5.1.12. | Skin patches with integrated electrodes |
| 5.2. | Reimbursement |
| 5.2.1. | Reimbursement codes for wearable cardiac monitors |
| 5.2.2. | 2021: New reimbursement structure in place |
| 5.2.3. | Fallout and outlook following the 2021 code change |
| 5.3. | Players |
| 5.3.1. | Summaries and interviews with 20 industry players |
| 5.3.2. | Philips |
| 5.3.3. | BioTelemetry, Inc. |
| 5.3.4. | BioTelemetry: Timeline |
| 5.3.5. | iRhythm |
| 5.3.6. | ScottCare |
| 5.3.7. | Fukuda Denshi |
| 5.3.8. | Fujita Medical Instruments |
| 5.3.9. | Bittium |
| 5.3.10. | Byteflies & Quad Industries |
| 5.3.11. | Cardiomo |
| 5.3.12. | Vivomi |
| 5.3.13. | QT Medical |
| 5.3.14. | SWMedical |
| 5.3.15. | SWMedical - CardiNova |
| 5.3.16. | Seers Technology |
| 5.3.17. | Rooti |
| 5.3.18. | Preventice Solutions |
| 5.3.19. | Sigknow |
| 5.3.20. | Borsam |
| 5.3.21. | Cortrium |
| 5.3.22. | Qardio |
| 5.3.23. | Qardio (2) |
| 5.3.24. | Holst Center: Skin patches |
| 5.3.25. | Tatch |
| 5.3.26. | Mezoo |
| 5.3.27. | S'UIMIN |
| 5.3.28. | Medtronic: SEEQ MCT (discontinued) |
| 5.3.29. | LumiraDx / FitLinxx: Ampstrip (discontinued) |
| 5.4. | Competition with other form factors |
| 5.4.1. | Other form factors for ambulatory cardiac monitoring |
| 5.4.2. | Wearable vs implantable monitoring |
| 5.4.3. | Example: Medtronic (SEEQ & LINQ) |
| 5.4.4. | Comparison: Chest straps |
| 5.4.5. | Comparison: Apparel |
| 5.4.6. | Comparison: Portable devices |
| 5.4.7. | Comparison: Smartwatch optical HRM |
| 5.5. | Market data and forecasts |
| 5.5.1. | Market overview and forecasts |
| 5.5.2. | The impact of COVID-19 |
| 5.5.3. | Cardiac monitoring skin patches: Historic data: 2010-2020 |
| 5.5.4. | Cardiac monitoring skin patches: Market forecasts |
| 5.5.5. | Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast) |
| 5.5.6. | Key conclusions: cardiac monitoring skin patches |
| 6. | FOETAL HEART RATE MONITORING |
| 6.1. | Foetal monitoring |
| 6.2. | Monica Healthcare |
| 6.3. | GE Healthcare |
| 6.4. | Philips |
| 6.5. | Key conclusions and market data |
| 7. | TEMPERATURE SENSING SKIN PATCHES |
| 7.1. | Introduction - Body Temperature |
| 7.2. | Temperature sensing technology options |
| 7.3. | Approaches and standards for medical temperature sensing |
| 7.4. | Skin patches for temperature sensing |
| 7.5. | Skin patch temperature sensing: Use cases across 13 case studies |
| 7.6. | VivaLNK |
| 7.7. | VivaLNK & Reckitt Benckiser |
| 7.8. | VivaLNK: COVID-19 response |
| 7.9. | BioIntelliSense |
| 7.10. | Blue Spark |
| 7.11. | Blue Spark & TempTraq® |
| 7.12. | Life Science Technology |
| 7.13. | Isansys Lifecare |
| 7.14. | Raiing Medical |
| 7.15. | Bonbouton |
| 7.16. | CSEM |
| 7.17. | Covestro |
| 7.18. | Chois Technology |
| 7.19. | Alternative options: Tympanic temperature sensing |
| 7.20. | Key conclusions: Temperature sensing skin patches |
| 8. | ELECTRICAL STIMULATION WITH SKIN PATCHES |
| 8.1.1. | Introduction: Types of electrical stimulation |
| 8.1.2. | Differentiation for electrical stimulation |
| 8.1.3. | Nomenclature in electrical stimulation |
| 8.1.4. | Electrical stimulation product types |
| 8.1.5. | Medical vs non-medical devices |
| 8.1.6. | Bioelectronic Medicine: Definition and background |
| 8.1.7. | Major Forms of Bioelectronic Medicine |
| 8.1.8. | The Evolution of Bioelectronic Medicine |
| 8.1.9. | Skin patches in bioelectronic medicine |
| 8.2. | TENS |
| 8.2.1. | TENS - Introduction |
| 8.2.2. | Innovative Health Solutions: NSS-2 Bridge |
| 8.2.3. | BeWellConnect: MyTens |
| 8.2.4. | NeuroMetrix: Quell |
| 8.2.5. | Theranica: Nerivio Migra |
| 8.3. | EMS / NMES / FES |
| 8.3.1. | EMS, NMES and FES |
| 8.3.2. | Applications of EMS / NMES |
| 8.3.3. | Example: Russian Stimulation |
| 8.3.4. | Example: Therapeutic settings and uses |
| 8.3.5. | Properties of the stimulation (as presented with a therapeutic focus) |
| 8.3.6. | First Kind Medical: geko |
| 8.3.7. | Example: HiDow |
| 8.3.8. | Example: HiDow |
| 8.3.9. | Hivox Biotek |
| 8.4. | Market data and forecasts |
| 8.4.1. | Electrical stimulation via skin patches: Market data (2010-2019) |
| 8.4.2. | Electrical stimulation via skin patches: Market forecast (2021-2031) |
| 9. | IONTOPHORESIS SKIN PATCHES: COSMETICS AND DRUG DELIVERY |
| 9.1.1. | Introduction - Iontophoresis |
| 9.1.2. | Cosmetics |
| 9.1.3. | Cosmetic skin patches |
| 9.1.4. | Estée Lauder |
| 9.1.5. | BioBliss™, Iontera, Patchology |
| 9.1.6. | FeeliGreen (Feeligold) |
| 9.2. | Drug delivery |
| 9.2.1. | Iontophoresis for drug delivery |
| 9.2.2. | Drugs studied for iontophoretic delivery |
| 9.2.3. | Commercial activity with drug delivery patches |
| 9.2.4. | FeeliGreen (Feelicare) |
| 9.2.5. | Seoul National University: Parkinson's medication via skin patches |
| 9.3. | Reverse iontophoresis |
| 9.3.1. | Reverse Iontophoresis |
| 9.3.2. | Example: GlucoWatch |
| 9.3.3. | Nemaura Medical: sugarBEAT |
| 9.4. | Market forecasts and conclusions |
| 9.4.1. | Iontophoresis via skin patches: Market data (2010-2019) |
| 9.4.2. | Iontophoresis via skin patches: Market forecast (2020-2030) |
| 9.4.3. | Key conclusions: Iontophoresis |
| 10. | SWEAT SENSING: SWEAT RATE AND BIOMARKERS |
| 10.1.1. | Introduction - Sweat sensing |
| 10.2. | Measuring sweat rate |
| 10.2.1. | Technology overview - measuring bioimpedance |
| 10.2.2. | Technology overview - Galvanic skin response (GSR) |
| 10.2.3. | Technology overview - humidity sensors for sweat |
| 10.2.4. | GE Global Research |
| 10.3. | Sensing biomarkers in sweat |
| 10.3.1. | Technology overview - chemical sensing in sweat |
| 10.3.2. | Sweat vs other sources of analytes |
| 10.3.3. | Analytes in sweat |
| 10.3.4. | Diagnostics with chemical sensors |
| 10.3.5. | Monitoring blood cholesterol using biosensors |
| 10.3.6. | Towards wearable cholesterol monitoring |
| 10.3.7. | Example: sweat alcohol detection |
| 10.3.8. | Lactic acid monitoring for athletes |
| 10.3.9. | Traditional lactic acid monitors |
| 10.3.10. | Microneedles to analyse lactic acid in interstitial fluid |
| 10.3.11. | Increasingly portable diagnosis of bovine and human TB |
| 10.3.12. | Wearable diagnostic tests for cystic fibrosis |
| 10.3.13. | Technology overview: Chemical sensing |
| 10.3.14. | Biolinq |
| 10.3.15. | Kenzen |
| 10.3.16. | Milo Sensors |
| 10.3.17. | PARC / UCSD |
| 10.3.18. | Stanford and UC Berkeley |
| 10.3.19. | Xsensio |
| 10.3.20. | Epicore Biosystems |
| 10.3.21. | Eccrine Systems (closed) |
| 10.3.22. | Key conclusions: Sweat sensing |
| 11. | WOUND MONITORING AND TREATMENT WITH SKIN PATCHES |
| 11.1. | Wound Monitoring |
| 11.2. | Wound Monitoring: KAUST |
| 11.3. | Wound Monitoring: Purdue University |
| 11.4. | Wound Monitoring: Tufts University |
| 11.5. | Wound Monitoring: Tyndall National Institute |
| 11.6. | Wound Monitoring: UC Berkeley |
| 11.7. | Wound Monitoring: UCSD |
| 11.8. | Wound Monitoring: VTT |
| 11.9. | Wound Treatment |
| 12. | MOTION SENSING WITH SKIN PATCHES |
| 12.1.1. | Introduction - Monitoring motion via skin patches |
| 12.1.2. | Different modes for sensing motion |
| 12.2. | Measuring motion with inertial measurement units |
| 12.2.1. | Introduction - Inertial measurement units |
| 12.2.2. | Measuring motion with IMUs: Examples |
| 12.2.3. | Value chain and examples of players |
| 12.2.4. | IMUs in skin patches |
| 12.3. | Measuring motion with conformal sensors |
| 12.3.1. | Introduction - alternatives for measuring motion |
| 12.3.2. | Technology overview - Resistive/piezoresistive sensing |
| 12.3.3. | Players and industry dynamic |
| 12.3.4. | Peratech |
| 12.3.5. | Quantum tunnelling composite: QTC® |
| 12.3.6. | QTC® vs. FSR™ vs. piezoresistor? |
| 12.3.7. | Bebop Sensors |
| 12.3.8. | Bainisha |
| 12.3.9. | Technology overview - Capacitive sensing |
| 12.3.10. | Parker Hannifin |
| 12.3.11. | Stretchsense |
| 12.3.12. | LEAP Technology |
| 12.3.13. | Technology overview - Piezoelectric sensing |
| 12.4. | Application examples |
| 12.4.1. | Applications for skin patch motion sensors |
| 12.4.2. | Case study - Concussion detection |
| 12.4.3. | X2 Biosystems |
| 12.4.4. | US Military head trauma patch / PARC |
| 12.4.5. | Key conclusions: Motion sensing |
| 13. | SKIN PATCHES AS A COMMUNICATION GATEWAY TO IMPLANTS |
| 13.1.1. | Communication with implants |
| 13.2. | Examples in diabetes management |
| 13.2.1. | Senseonics |
| 13.2.2. | Senseonics: The role of the skin patch |
| 13.3. | Examples in bioelectronic medicine |
| 13.3.1. | Skin patches with bioelectronic medicine implants |
| 13.3.2. | NeuroRecovery Technologies |
| 13.3.3. | Stimwave: Freedom SCS |
| 13.3.4. | SPR Therapeutics: Sprint PNS |
| 13.3.5. | Bioness: StimRouter |
| 13.4. | Other examples |
| 13.4.1. | Proteus Digital Health |
| 13.4.2. | GraftWorx |
| 14. | OTHER APPLICATIONS OF SKIN PATCHES |
| 14.1. | Pressure ulcer prevention |
| 14.1.1. | Leaf Healthcare (Smith & Nephew) |
| 14.2. | Bladder volume sensing (wearable ultrasound) |
| 14.2.1. | Novioscan |
| 14.2.2. | Triple W - D Free |
| 14.3. | Other healthcare & medical applications |
| 14.3.1. | Acoustic respiration rate (Acurable, Masimo, etc.) |
| 14.3.2. | UV protection |
| 14.3.3. | MC10 & L'Oréal: Wisp |
| 14.3.4. | Lief Therapeutics: Stress Management |
| 14.4. | Others |
| 14.4.1. | EOG - eye tracking with skin patches |
| 15. | MARKET FORECASTS |
| 15.1.1. | Forecast details and assumptions |
| 15.2. | Diabetes management forecasts |
| 15.2.1. | Skin patches and diabetes: Forecast summary |
| 15.2.2. | Overview: CGM market share and players in 2020 |
| 15.2.3. | A shifting focus in diabetes management, Historic data: 2010-2020 |
| 15.2.4. | Historic market data: Glucose test strips |
| 15.2.5. | Historic market data: CGM |
| 15.2.6. | Historic market data: Insulin pumps |
| 15.2.7. | Historic market data: Patch pumps |
| 15.2.8. | Quantitative forecasts for diabetes and CGM |
| 15.2.9. | Building a top-down forecast scenario |
| 15.2.10. | Market data and forecast: Glucose test strips |
| 15.2.11. | Market data and forecast: CGM (sales volume) |
| 15.2.12. | Market data and forecast: Insulin pumps (revenue) |
| 15.2.13. | Market data and forecast: Insulin pumps (sales volume) |
| 15.2.14. | Full datasets: Skin patches in diabetes management, 2010-2020 (historic) & 2021-2031 (forecast) |
| 15.2.15. | Full datasets: Diabetes management markets, 2010-2020 (historic) & 2021-2031 (forecast) |
| 15.3. | Cardiovascular monitoring forecasts |
| 15.3.1. | Market overview and forecasts |
| 15.3.2. | Cardiac monitoring skin patches: Historic data: 2010-2020 |
| 15.3.3. | Cardiac monitoring skin patches: Market forecasts |
| 15.3.4. | Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast) |
| 15.4. | General patient monitoring forecasts |
| 15.4.1. | Historic market data, 2010-2020 |
| 15.4.2. | Market forecasts, 2021-2031 |
| 15.4.3. | Market data and forecasts for wireless inpatient monitoring |
| 15.4.4. | Market data and forecasts for wireless outpatient monitoring |
| 15.4.5. | Foetal heart rate monitor forecasts |
| 15.5. | Electrical stimulation forecasts |
| 15.5.1. | Electrical stimulation via skin patches: Market data (2010-2019) |
| 15.5.2. | Electrical stimulation via skin patches: Market forecast (2021-2031) |
| 15.6. | Temperature sensing forecasts |
| 15.6.1. | Temperature sensing: Market data and forecasts |
| 15.7. | Iontophoresis forecasts |
| 15.7.1. | Iontophoresis via skin patches: Market data (2010-2019) |
| 15.7.2. | Iontophoresis via skin patches: Market forecast (2020-2030) |
| 15.8. | Full historic and forecast data tables for all sectors |
| 15.8.1. | Revenue by skin patch product type (/USD millions) |
| 15.8.2. | Pricing by skin patch product type (/USD) |
| 15.8.3. | Revenue by skin patch product type (/USD millions) |
| 16. | LIST OF 121 ELECTRONIC SKIN PATCH PRODUCTS AND PLAYERS |
| 16.1. | List of company profiles and interviews |
The market for electronic skin patches will be worth over $30bn per year by 2031
报告统计信息
| 幻灯片 | 503 |
|---|---|
| 预测 | 2031 |
Customer Testimonial
"The resources produced by IDTechEx are a valuable tool... Their insights and analyses provide a strong foundation for making informed, evidence-based decisions. By using their expertise, we are better positioned to align our strategies with emerging opportunities."